Thoracic Cancer (Apr 2023)

Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors

  • Chunwei Xu,
  • Yongchang Zhang,
  • Wenxian Wang,
  • Qian Wang,
  • Ziming Li,
  • Zhengbo Song,
  • Jiandong Wang,
  • Jinpu Yu,
  • Jingjing Liu,
  • Shirong Zhang,
  • Xiuyu Cai,
  • Ming Wu,
  • Ping Zhan,
  • Hongbing Liu,
  • Tangfeng Lv,
  • Liyun Miao,
  • Lingfeng Min,
  • Jiancheng Li,
  • Baogang Liu,
  • Jingping Yuan,
  • Zhansheng Jiang,
  • Gen Lin,
  • Xiaohui Chen,
  • Xingxiang Pu,
  • Chuangzhou Rao,
  • Dongqing Lv,
  • Zongyang Yu,
  • Xiaoyan Li,
  • Chuanhao Tang,
  • Chengzhi Zhou,
  • Junping Zhang,
  • Hui Guo,
  • Qian Chu,
  • Rui Meng,
  • Xuewen Liu,
  • Jingxun Wu,
  • Xiao Hu,
  • Min Fang,
  • Jin Zhou,
  • Zhengfei Zhu,
  • Xiaofeng Chen,
  • Weiwei Pan,
  • Fei Pang,
  • Yuxiang Zhou,
  • Qijie Jian,
  • Kai Wang,
  • Liping Wang,
  • Youcai Zhu,
  • Guocai Yang,
  • Xinqing Lin,
  • Jing Cai,
  • Lijun Liang,
  • Huijing Feng,
  • Lin Wang,
  • Yingying Du,
  • Wang Yao,
  • Xuefei Shi,
  • Xiaomin Niu,
  • Dongmei Yuan,
  • Yanwen Yao,
  • Jianhui Huang,
  • Yinbin Zhang,
  • Pingli Sun,
  • Hong Wang,
  • Mingxiang Ye,
  • Dong Wang,
  • Zhaofeng Wang,
  • Yue Hao,
  • Zhen Wang,
  • Bing Wan,
  • Donglai Lv,
  • Genhua Yu,
  • Anna Li,
  • Jin Kang,
  • Jiatao Zhang,
  • Chao Zhang,
  • Huafei Chen,
  • Lin Shi,
  • Leiguang Ye,
  • Gaoming Wang,
  • Yina Wang,
  • Feng Gao,
  • Wei Zhou,
  • Chunxiu Hu,
  • Jianguo Wei,
  • Bihui Li,
  • Zhongwu Li,
  • Yuan Li,
  • Zhefeng Liu,
  • Nong Yang,
  • Lin Wu,
  • Qiming Wang,
  • Wenbin Huang,
  • Zhuan Hong,
  • Guansong Wang,
  • Meiyu Fang,
  • Yong Fang,
  • Xixu Zhu,
  • Kaiqi Du,
  • Jiansong Ji,
  • Yi Shen,
  • Yiping Zhang,
  • Shenglin Ma,
  • Yong Song,
  • Yuanzhi Lu,
  • Anwen Liu,
  • Wenfeng Fang,
  • Wenzhao Zhong

DOI
https://doi.org/10.1111/1759-7714.14847
Journal volume & issue
Vol. 14, no. 12
pp. 1102 – 1117

Abstract

Read online

Abstract Thymic epithelial tumors (TETs) are a relatively rare type of thoracic tumor, accounting for less than 1% of all tumors. The incidence of TETs is about 3.93/10000 in China, slightly higher than that of European and American countries. For resectable TETs, complete surgical resection is recommended. Radiotherapy or chemotherapy may be used as postoperative adjuvant treatment. Treatment for advanced, unresectable TETs consist mainly of radiotherapy and chemotherapy, but there is a lack of standard first‐ and second‐line treatment regimens. Recently, targeted therapies and immune checkpoint inhibitors have shown promising outcomes in TETs. Based on the currently available clinical evidences and the opinions of the national experts, the Thymic Oncology Group of Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caNcer Group, ECLUNG; Youth Committee) established this Chinese expert consensus on the clinical diagnosis and treatment of TETs, covering the epidemiology, diagnosis, treatment, prognosis and follow‐up of TETs.

Keywords